Advertisement Medicure names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Medicure names new CFO

Medicure, a cardiovascular-focused biopharmaceutical company, has appointed Dwayne Henley as its new CFO.

Mr Henley joins Medicure from a private investment and management company where he held the position of vice president of finance. Prior to that Mr Henley’s was vice-president finance for a privately owned transportation company operating throughout North America.

Mr Henley is a chartered accountant with nearly 10 years of senior management and finance experience in both public and private companies. He will replace, Derek Reimer, who has resigned to pursue other interests.

Albert Friesen, president and CEO of Medicure, said: “We are very pleased to have someone with Dwayne Henley’s broad financial and public markets experience join our team. We are also very appreciative of Derek Reimer’s contributions and wish him well in his future endeavors.”